# Coherus Oncology, Inc.: Form 8-K, filed May 11, 2026

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: 8-K
- Filed: 2026-05-11
- Accepted by EDGAR: May 11, 2026, 16:16 ET
- Period: 2026-05-11
- Accession: 0001104659-26-058666
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000110465926058666/chrs-20260511x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000110465926058666/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000110465926058666/chrs-20260511x8k.htm

Filed May 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-058666. Last ingested by Listed: Nov 10, 2026, 03:58 ET. No prices; not investment advice.